Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Topline headwinds remain but margins improving

Articore
3:27pm
February 27, 2024
Articore Group’s (ATG) 1H24 marketplace revenue (MPR) was ~5% under consensus at ~A$260m (-13% on pcp on a constant currency basis) but broadly in line with consensus at GPAPA (~A$64m, +19% on pcp). Whilst management initiatives around improving the margin profile of the business appear on track, we note ATG expects the softer consumer environment to persist into the 2H and hence topline growth eludes at this juncture. We make several adjustments to our medium-term forecasts, predominantly related to: 1) the lower marketplace revenue environment; and 2) the narrowed FY24 margin guidance (details below). Our price target is altered marginally to A$0.70 from (A$0.71). Hold maintained.

1H in line- Working on a “step-change” in core ops

Healius
3:27pm
February 27, 2024
1H results were pre-released so in line, with underlying Op income falling by double-digits and margins compressing. Pathology was the main drag, negatively impacted by cycling out of covid-19 testing, combined with low volumes and cost inflation, while Lumus Imaging was “ahead of target” on strength in the hospital and community segments, and Agilex showed “positive signs” on increasing new contracts. While management is accelerating Pathology restructuring to better match volumes with costs, aiming for a “step-change” by FY26/27, uncertainty around the impact of numerous initiatives make forecasting challenging and unreliable. We lower our FY24-26 estimates, with our target price decreasing to A$1.32. Hold

Execution on point

SiteMinder
3:27pm
February 27, 2024
1H24 underlying EBITDA/NPAT was below MorgansF and consensus. Subscribers, revenue, and cashflow were pre-released at SDR’s 2Q24 update. The highlight for us was SDR continuing to demonstrate ongoing improvement in its profitability and unit economics whilst maintaining solid growth momentum. Management said the 2H24 has started well and reiterated FY24 guidance for positive underlying EBITDA and FCF in 2H24. SDR continues to target medium-term organic revenue growth of 30%. We continue to think SDR offers an attractive long-term growth opportunity underpinned by its global underpenetrated TAM and opportunity to better monetise its A$70bn of Gross Booking Value (currently captures ~0.2%). ADD maintained.

Growing across all regions

Polynovo
3:27pm
February 27, 2024
PNV posted its 1H24 results which was in line with our forecasts. Sales momentum across all regions is continuing and we have upgraded our sales forecasts which sees average growth of 32% pa over the next three years. As a result of upgrades to forecasts our TP has increased to A$2.22, and with >10% upside to the target we upgrade our recommendation to Add (from Hold).

Improving profitability but some top-line headwinds

Tyro Payments
3:27pm
February 27, 2024
TYR’s 1H24 normalised gross profit (A$105m) was +~11% on the pcp and in-line with consensus (A$105m), whilst the 1H24 normalised EBITDA (A$27m, +41% on the pcp) was slightly below consensus (-3%).  While 1H24 showed good overall profitability trends, in our view, some issues with the Bendigo Alliance and a tougher core business transaction environment point to a softer top-line outlook in 2H24. We reduce our TYR FY24F/FY25F EBITDA figures by -6%-12% mainly on lower transaction value forecasts. While our EPS estimates in FY24F rise on lower share-based payments, FY25F EPS declines by -13%. Our PT is set at A$1.47 (previously A$1.61). We see recent improvements in TYR’s underlying operating performance as encouraging, and think there remains long-term value in the name. ADD.

1H24 result: Not flying yet, but the bags are packed

Aerometrex
3:27pm
February 27, 2024
AMX has released its 1H report in-line with our expectations. Key focus remains on Annual Recurring Revenue (ARR) growth and cost controls, both improving over the last 12 months. LiDAR growth continues to grab the headlines, but we’re getting the sense MetroMap is back on track with the worst now behind it following a number of years contending with competitive pressures and aviation constraints. We retain an Add recommendation on AMX and continue to see an attractive risk/reward profile with clearer skies ahead. Our valuation and target price increases marginally to A$0.50 p/s (from A$0.45 p/s).

A reboot and ready to fly

ImpediMed
3:27pm
February 27, 2024
IPD released its 1H24 results which were in line with expectations. The new CEO and CFO have set out a clear plan to focus on high volume US states (targeting 11 states by April) and cost control (reduction 10% to 15%). The market will appreciate this clarity. We have made no changes to forecasts, target price or recommendation.

Margin pressure leaves PPE an FY25 story

PeopleIn
3:27pm
February 26, 2024
A challenging economic environment saw PPE’s margins continue to deteriorate both qoq, hoh and yoy, resulting in EBITDA declining 38% yoy. Management called out a decline in contract rates, permanent recruitment fees and government subsidies as the primary drivers. However, not much of this is new, with management having previously flagged the challenging environment at the FY23 result (Aug-23) and at the AGM (Nov-23). What did surprise was the level of margin degradation qoq, as the business was impacted by a declining contract rate - customers filling more lower skilled, lower margin roles. To this end, management are expecting higher margin demand to start improving in FY25. Given that operating conditions are likely to remain challenging for the next twelve months and terminal margins are likely lower than first anticipated, we downgrade to a hold rating, reducing our valuation to $1.05/sh.

Consumers remain value-conscious

Endeavour Group
3:27pm
February 26, 2024
EDV’s 1H24 result was slightly above expectations. Key positives: Group EBIT margin was flat at 9.9% with cost out initiatives offsetting cost inflation; Cash realisation was strong at 140% (vs 99% in the pcp). Key negatives: ROFE was down 60bp to 11.6%; Full year net interest expense is now expected to be between $300-310m (vs $280-310m previously). For the first seven weeks of 2H24, Retail sales were broadly flat (+0.3%) reflecting subdued sales in January followed by an improvement in February. Hotels sales were 1% higher. We decrease FY24-26F underlying EBIT by 1% while underlying NPAT reduces by between 3-4% due to higher net interest expense. Our target price rises slightly to $5.20 (from $5.15) despite the decrease in earnings forecasts largely due to a roll-forward of our model to FY25 forecasts. Hold rating maintained. While EDV is a good business, trading on 17.1x FY25F PE and 4.3% yield we think the stock is fully valued given the subdued near-term outlook with consumers remaining cautious.

General insurance profitability heading the right way

Suncorp Group
3:27pm
February 26, 2024
SUN’s 1H24 NPAT (A$582m) was -2% below consensus ($596m). The 1H24 dividend (A34cps) was in line with consensus. Overall we saw the general insurance result as broadly sound (outside some reserve strengthening), with it indicating a likely improving trajectory in 2H24 and FY25. Whilst the bank result was weak, this arguably highlights the reasons/benefit of exiting this business. We lower SUN FY24F/FY25 EPS by -7%/-3% on a model update for the new AASB17 accounting standards, reduced bank earnings forecasts, and an adjustment to capital return estimates post the bank sale (A$4bn vs A$4.2bn previously). Our PT is set at A$16.88 (previously A$16.42) on a valuation roll-forward. With SUN still having >10% TSR upside on a 12-month view, we maitain our ADD rating.

News & Insights

In recent weeks, there has been much discussion about the inflationary effect of Trump tariffs. Our Chief Economist, Michael Knox shares his views.

In recent weeks, there has been much discussion about the inflationary effect of Trump tariffs. This is sparked by Donald J. Trump's proposal of a 10% revenue tariff. Interestingly, the idea of a 10% revenue tariff was first discussed during his first term. At that time, it was considered as a potential source of additional revenue to offset the Trump tax cuts enacted during his first term.

The challenge in passing finance bills in the U.S. lies in the legislative process. Finance bills can only be easily passed if they are reconciliation bills, meaning they have no effect on the budget balance. When a finance bill does not affect the budget balance, it requires only a simple majority in the U.S. Senate to pass. However, when a finance bill increases the budget deficit, it requires at least 60-votes in the Senate, making such bills much harder to pass.

During Trump's first term, the administration found that by reducing certain tax write offs or tax cuts for specific states, they could pass the overall tax bill without effecting the budget balance. This allowed significant tax cuts for individuals and a major corporate tax cut, reducing the U.S. corporate tax rate from 35% to 21%. Now, as Trump seeks to cut corporate taxes again—this time from 21% to 15%, matching the German corporate tax rate—he needs additional revenue to balance the bill. This is so he can pass it as a reconciliation bill, requiring only 51 Senate votes. This has led to renewed discussions about the 10% revenue tariff.

In contrast to the European Union, where a value-added tax (VAT) would be a straightforward solution, implementing a VAT in the U.S. is effectively impossible due to constitutional constraints. A VAT would require unanimous agreement from all states. This is impossible in practise. So, the idea of a 10% revenue tariff has resurfaced.

Critics, particularly within the Democratic Party, have argued that such a tariff would be highly inflationary. However, when questioned during confirmation hearings, Trump's Treasury secretary nominee, Scott Bessent, referencing optimal tariff theory, explained that a 10% revenue tariff would increase the U.S. dollar exchange rate by 4%. We note that this would result in a maximum inflationary effect of 6% only if 100% of domestic goods were imported. Given that only 13% of domestic goods are imported, the actual inflationary impact would be just 0.8% on the Consumer Price Index (CPI). This makes the tariff effectively inflation neutral.

This idea was discussed by a panel of distinguished economists at the American Economic Association Convention in January, including Jason Furman, Christy Romer, Ben Bernanke, and John Cochrane. Cochrane noted that historical instances of tariff increases, such as in the 1890s and 1930s, did not lead to inflation because monetary policy was tight. He argued that the inflationary impact of tariffs depends entirely on the Federal Reserve's monetary policy. If the Fed maintains a firm stance, there would be no inflationary effect.

Trump's current plan is to pass a comprehensive bill that includes the Reciprocal Trade Act, corporate tax cuts, and the 10% revenue tariff. Peter Navarro, in a CNBC interview on 21 January, estimated that the revenue tariff could generate between $US350and$US400 billion, offsetting the cost of the tax cuts and making the bill feasible as a reconciliation measure.

With the Republican Party holding enough Senate seats, the legislation could pass by the end of April. The inflationary impact of the tariff, estimated at 0.8%, can be easily managed through moderately tight monetary policy by the Federal Reserve.


Morgans clients receive access to detailed market analysis and insights, provided by our award-winning research team. Begin your journey with Morgans today to view the exclusive coverage.

      
Contact Us
      
Read more
Michael Knox discusses the challenges the Reserve Bank of Australia (RBA) faces in cutting rates. He explores a model of Australian short-term interest rates, and how its components interact.

Today, I want to discuss the challenges the Reserve Bank of Australia (RBA) faces in cutting rates. To do this, I’ll explore our model of Australian short-term interest rates, and how its components interact. A key focus will be the relationship between inflation and unemployment, and how this relationship makes it particularly difficult for the RBA to now lower rates.

Our model of the Australian cash rate is robust, explaining just under 90% of the monthly variation in the cash rate since the 1990s, when the cash rate was first introduced. The model’s components include core inflation (not headline inflation), unemployment, and inflation expectations.

Interestingly, statistical tests show that unemployment is even more important than inflation when it comes to predicting what the RBA will do with the cash rate. This is because of the strong, leading relationship between Australian unemployment and core inflation.

To illustrate this, I’ve used data from the past ten years up until December, which shows the relationship between unemployment and inflation in Australia. The data reveals a Phillips curve, where inflation tends to fall as unemployment rises. This relationship begins to work appears almost immediately, though there is a slight delay of about 3 to 4 months before its full effect is felt.

We look at the data from 2014 to the end of 2024. When unemployment is around 4%—which is where it has been for the past few months—we can predict that core inflation should be around 3.7%. Currently, core inflation is 3.5%, which aligns closely with what we would expect given the unemployment rate. This suggests that the current level of inflation is consistent with current unemployment levels.

Unemployment vs Inflation

2014 to 2024

However, the RBA’s target inflation rate is between 2 and 3%, with a specific target of 2.5%. To achieve this target, unemployment would need to rise from its current level of 4% to around 4.6% or 4.7%. Historical data, such as from 2021, shows that with an unemployment rate of around 4.6%, inflation can be brought down to 2.5%. Therefore, to reduce inflation to the RBA’s target, the unemployment rate would need to increase slightly—though not drastically. If unemployment were allowed to rise to around 4.6%, it would create enough excess capacity in the economy to put downward pressure on inflation, which would take about 3 to 4 months to materialise.

If the RBA were able to allow this rise in unemployment, inflation would decrease to around 2.5%, and the RBA could cut rates. Current rates are at 4.35%, and under this scenario, we could expect them to drop to the low 3.0% range perhaps even lower. This would represent a fall of around 100 basis points from current levels.

Unfortunately, the situation is complicated by fiscal policy. The current Treasurer, Jim Chalmers, has been expanding employment in sectors like the National Disability Insurance Scheme (NDIS) and other areas of the public service. This fiscal stimulus is preventing unemployment from rising to the level needed for inflation to fall. As a result, unemployment remains stuck at around 4%, and inflation remains too high for the RBA to cut rates.

In terms of job vacancies and other labour market indicators, we would have expected unemployment to rise higher by now. However, Treasurer Chalmers is committed to keeping unemployment low ahead of the election, which is why we find ourselves in this position.

The government’s fiscal policy, aimed at maintaining a low unemployment rate, is preventing the necessary adjustment to bring inflation down.

If I input the current levels of inflation, unemployment, and inflation expectations into our model, the estimated cash rate should be 4.45%. This is 10 basis points higher than the current cash rate of 4.35%.

The Australian Government seems intent on maintaining the unemployment rate at 4% ahead of the election. If it does so, Inflation will remain too high for the RBA to cut rates.

Read more
The federal government has recommended a number of changes to the cost of residential aged care, which will commence from the beginning of 2025. Read more about the main measures to be introduced.

Following the release of the Aged Care Taskforce report earlier this year, the federal government has recommended a number of changes to the cost of residential aged care, some will commence from the beginning of 2025 and the remainder expected to commence from 1 July 2025.

Over the next 40 years, the number of people over 65 is expected to at least double and the number of people over 85 expected to triple. A significant amount needs to be invested in the Aged Care sector, by both government and private sector, to be able to manage the growing numbers of older people needing care and support in their later years.

From 1 January 2025:

  • Increasing the refundable accommodation deposit (RAD) maximum amount without approval from $550,000 to $750,000. This amount will be indexed annually.

From 1 July 2025:

  • Introduce a RAD retention amount of 2% pa to a maximum of 10% over 5 years.
  • Removing the annual fee caps and increasing the lifetime fee caps to $130,000 or 4 years, whichever occurs first.
  • Introducing a means-tested hotelling supplement of $12.55 per day which is to be indexed.
  • Removing the means tested fee and replacing it with a means tested non-clinical care contribution (NCCC). The daily maximum is $101.16 which is to be indexed.

From 2029/30:

  • The government is looking to commence a phase out RAD altogether by 2035. A commission will be established to independently review the sector in readiness.

Grandfathering arrangements will protect anyone who enters care prior to 1 July 2025 under the “no worse off” principle to ensure they do not pay more for their care.

Comparison of current and new aged care costs

Current aged care fees

The Basic Daily fee continues to be paid by all residents without change.

The Hotelling Supplement is paid by residents as a contribution towards their living costs. It is a means tested payment calculated at 7.8% of assets greater than $238k or 50% of income over $95,400 (or a combination of both). The Hotelling Supplement is capped at $12.55 per day (indexed).

The Non-Clinical Care Contribution (NCCC) replaces the current means tested fee. The NCCC is a contribution towards the cost of non-clinical care services which will be capped at $101.16 per day (indexed). It is a means tested fee calculated at 7.8% of assets over $501,981 or 50% of income over $131,279 (or a combination of both).

The lifetime cap for the NCCC is increasing to $130,000 or 4 years, whichever occurs first, indexed twice per year. There is no longer an annual cap.

Any contributions made under the home support program prior to entering residential aged care will count towards the NCCC cap.

Who will likely pay more from 1 July 2025?

It is expected that at least 50% of people entering care will pay more for their care each year.

The below chart illustrates the expected changes for regular care costs (excluding accommodation costs and retention amounts) for individuals based on specific asset levels:

Should you enter residential aged care before 1 July 2025?

It depends. For some people, if they have an ACAT assessment and are eligible to enter residential aged care, then it would be best to seek advice from your Morgans Adviser on both the current and future cost as well as cash flow and cost funding advice.


Contact your Morgans adviser today to schedule an aged care advice appointment. Our expert team will be able to simplify the aged care system, guide you through Government subsidies, analyse payment options, create 5-year cash flow projections, and model the benefits of home concessions and future asset values for your beneficiaries.

      
Contact Us
      
Read more